Lacosamide
NDC 68462-940, Lacosamide, solution, from Glenmark Pharmaceuticals Limited.
- Product NDC
- 68462-940
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Limited
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215379
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/68462-940 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-940-86 | 68462094086 | 200 mL in 1 BOTTLE, PLASTIC (68462-940-86) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/458e80da-8fc1-4715-9b4b-bc4f388f933fNADAC price for package 68462094086
GET /v1/drugs/nadac/68462094086
Use it
Look up 68462-940 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-940 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-940. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.